Announcements Trials

Browse Landscape

Phase

Phase 2 19 Phase NA 6 Phase 1 4 Phase 4 2 Phase 3 2 Phase 1/2 2 Phase 2/3 1

Status

Unknown 1 Terminated 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Carcinoma, Hepatocellular 27 Neoplasms 19 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Stomach Neoplasms 15 Leukemia, Myeloid, Acute 15 Prostatic Neoplasms 12 Lung Neoplasms 12 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Rectal Neoplasms 10 Neoplasm Metastasis 8 Leukemia 8 Pancreatic Neoplasms 7 NSCLC 6 Multiple Myeloma 6 Liver Neoplasms 6 Esophageal Neoplasms 6 Glioblastoma 5 Small Cell Lung Carcinoma 4 Recurrence 4 Polycystic Ovary Syndrome 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Gestational Trophoblastic Disease 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4

Interventions

Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Unknown × Adenocarcinoma of Lung × Clear all

NCT03380468 2023-07-20

ECTOP-1004

Fudan University

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡